Specially packaged DNA secreted by tumor cells can trigger an immune response that inhibits the metastatic spread of the tumor to the liver, according to a study led by researchers at Weill Cornell Medicine.
Severe COVID-19 arises in part from the SARS-CoV-2 virus’s impact on mitochondria, tiny oxygen-burning power plants in cells, which can help trigger a cascade of organ- and immune system-damaging events, suggests a study by investigators at Weill Cornell Medicine.
A preclinical trial has identified a way to thwart the highly addictive nature of opioids such as morphine and oxycodone while maintaining the drugs’ ability to relieve pain.
Inhibiting an immune signaling protein may help preserve the protective layer surrounding nerve fibers in the brain during both Alzheimer’s disease and ordinary aging, a new study suggests.
The installation designed by AAP's Jennifer Newsom and Tom Carruthers is one of nearly 200 artworks featured in the Metropolitan Museum of Art's "Flight into Egypt: Black Artists and Ancient Egypt, 1876-Now" exhibition, open through Feb. 17.
A fungus discovered in the mouse stomach may hold a key to fungal evolution within the gastrointestinal tract, according to new research led by Weill Cornell Medicine investigators.
The new injectable weight-loss drug reduced the risk of diabetes in patients with obesity and prediabetes by more than 90% over a three-year period, compared with placebo.
The secret to cellular youth may depend on keeping the nucleolus – a condensed structure inside the nucleus of a cell – small, according to Weill Cornell Medicine investigators.
A novel combination of surgery and embolization used to treat subdural hematomas, bleeding between the brain and its protective membrane due to trauma, reduces the risk of follow-up surgeries, according to researchers at Weill Cornell Medicine and University at Buffalo.
